8 studies found for:    MABT
Show Display Options
Rank Status Study
1 Completed A Study of the Safety, Tolerability, Pharmacokinetics, and Bioavailability of IV and SC MABT5102A in Healthy Volunteers
Condition: Healthy Volunteer
Intervention: Drug: MABT5102A
2 Completed A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A;   Drug: placebo
3 Completed A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A;   Drug: placebo
4 Completed A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: anti-Abeta;   Drug: placebo
5 Completed Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion
Condition: Chronic Hypersecretions
Interventions: Device: TPEP device (UNIKO);   Procedure: MABT (Manually assisted breathing techniques)
6 Recruiting Body-oriented Therapy for Women in SUD Treatment
Condition: Substance Use Disorder
Interventions: Behavioral: Mindful Awareness in Body-oriented Therapy;   Behavioral: Womens Health Education
7 Completed Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment
Condition: Substance Use Disorder
Intervention: Behavioral: Mindful Awareness in Body-oriented Therapy
8 Active, not recruiting A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: rituximab [MabThera];   Drug: fludarabine;   Drug: cyclophosphamide;   Drug: chlorambucil

Indicates status has not been verified in more than two years